Fishy Whales
Security

ALNY · Alnylam Pharmaceuticals Inc

40 institutional holder(s) · 5 congressional trade(s)
← Funds
Alnylam Pharmaceuticals Inc is a company in the Health Care sector, identified from SEC filings. It is held by 12 of 26 tracked funds in the latest quarter and traded by 3 members of Congress in disclosed filings.

Institutional holders

13F
FundValueShares
Vanguard Group $4.93B12,397,073
Fidelity $3.42B10,336,958
BlackRock $1.28B3,863,938
State Street $1.1B3,322,698
BlackRock $1.08B3,267,436
Fidelity $845.3M2,554,834
Geode Capital Management $771.9M2,319,764
Two Sigma Investments $659.3M1,992,577
Fidelity $367.5M1,110,583
Vanguard Group $327.6M823,784
BlackRock $319M964,063
Bank of America $183M553,116
Fidelity $151.4M457,502
Millennium Management $148.2M447,887
BlackRock $144.2M435,832
BlackRock $115.8M349,870
Geode Capital Management $112.7M340,621
BlackRock $107.7M325,552
Bank of America $101.5M306,804
Morgan Stanley $96.5M291,799
Morgan Stanley $92.5M279,605
Vanguard Group $82.4M207,271
BlackRock $62.5M188,876
BlackRock $62.5M188,753
Morgan Stanley $56.7M171,356
BlackRock $48.9M147,806
Morgan Stanley $48M144,937
BlackRock $45.3M136,917
BlackRock $40.6M122,783
BlackRock $39.4M119,060
Fidelity $38.4M115,938
BlackRock $36.9M111,432
Bridgewater Associates $35.3M106,592
BlackRock $34.9M105,363
State Street $29.3M22,770,000
Vanguard Group $25.7M64,553
Vanguard Group $24.4M61,251
BlackRock $21.3M16,600,000
Morgan Stanley $17.1M51,713
Citadel Advisors $16.7M50,600

Congressional trades

STOCK Act
MemberTypeDate
Jefferson Shreve sell 05/12/2025
Josh Gottheimer sell 01/29/2024
Josh Gottheimer buy 01/11/2024
Josh Gottheimer buy 09/28/2022
Richard L. Hanna buy 10/13/2016